Inventor · disambiguated record
David B. Passmore
Also filed as: PASSMORE DAVID · PASSMORE DAVID B
27 granted patents·11 pending applications·2,612 citations·filing 1998–2022
97Inventor score
Top patents by PatentIndex Score
38 records- 0199US9580507B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)SQUIBB & SONS LLC·Filed 2016·Granted Feb 28, 2017·129 cites·30 claims
- 0299US9273135B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)SQUIBB & SONS LLC·Filed 2015·Granted Mar 1, 2016·109 cites·30 claims
- 0399US9102725B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)MEDAREX INC·Filed 2013·Granted Aug 11, 2015·120 cites·31 claims
- 0499US8383796B2Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1)MEDAREX INC·Filed 2011·Granted Feb 26, 2013·355 cites·31 claims
- 0599US7943743B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)MEDAREX INC·Filed 2006·Granted May 17, 2011·1.5k cites·26 claims
- 0698US9580505B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)SQUIBB & SONS LLC·Filed 2015·Granted Feb 28, 2017·37 cites·41 claims
- 0795US7875278B2Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residuesMEDAREX INC·Filed 2006·Granted Jan 25, 2011·56 cites·14 claims
- 0893US8461117B2Chemical linkers and cleavable substrates and conjugates thereofSUFI BILAL·Filed 2007·Granted Jun 11, 2013·61 cites·9 claims
- 0992US8258266B2IP-10 antibodies and their usesDESHPANDE SHRIKANT·Filed 2009·Granted Sep 4, 2012·28 cites·17 claims
- 1092US8097703B2CD19 antibodies and their usesRAO-NAIK CHETANA·Filed 2006·Granted Jan 17, 2012·71 cites·20 claims
- 1190US8481683B2Human antibodies that bind CD22 and uses thereofKING DAVID JOHN·Filed 2007·Granted Jul 9, 2013·31 cites·20 claims
- 1290US8247537B2Human monoclonal antibodies to BTLA and methods of useKORMAN ALAN·Filed 2007·Granted Aug 21, 2012·20 cites·18 claims
- 1389US8580259B2Human monoclonal antibodies to BTLA and methods of useKORMAN ALAN·Filed 2012·Granted Nov 12, 2013·15 cites·43 claims
- 1487US7741449B2Anti-interferon alpha antibodiesMEDAREX INC·Filed 2004·Granted Jun 22, 2010·19 cites·16 claims
- 1586US9499632B2Human antibodies that bind CD22 and uses thereofSQUIBB & SONS LLC·Filed 2013·Granted Nov 22, 2016·8 cites·42 claims
- 1684US8025882B2Interferon alpha antibodies and their usesMEDAREX INC·Filed 2009·Granted Sep 27, 2011·4 cites·12 claims
- 1782US2023061544A1Human monoclonal antibodies to programmed death ligand 1 (pd-l1)SQUIBB & SONS LLC·Filed 2022·Application pending·0 cites
- 1879US8188235B2Antibodies to IL-6 and their usesRAJPAL ARVIND·Filed 2009·Granted May 29, 2012·3 cites·10 claims
- 1976US8461308B2Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residuesCARDARELLI JOSEPHINE M·Filed 2010·Granted Jun 11, 2013·3 cites·22 claims
- 2074US8945546B2IP-10 antibodies and their usesDESHPANDE SHRIKANT·Filed 2012·Granted Feb 3, 2015·2 cites·21 claims
- 2174US8722870B2Nucleic acids encoding interferon alpha antibodiesMEDAREX INC·Filed 2013·Granted May 13, 2014·1 cites·20 claims
- 2274US6417330B1Insulin-like growth factor binding protein variantsCELTRIX PHARMA·Filed 1999·Granted Jul 9, 2002·22 cites·8 claims
- 2373US9994633B2IP-10 antibodies and their usesSQUIBB & SONS LLC·Filed 2014·Granted Jun 12, 2018·1 cites·4 claims
- 2472US6436897B2Pharmaceutical formulations for IGF/IGFBPCELTRIX PHARMA·Filed 1998·Granted Aug 20, 2002·30 cites·25 claims
- 2571US2020062848A1Human monoclonal antibodies to programmed death ligand 1 (pd-l1)SQUIBB & SONS LLC·Filed 2019·Application pending·0 cites
- 2669US8475797B2Interferon alpha antibodies and their usesWITTE ALISON·Filed 2011·Granted Jul 2, 2013·2 cites·15 claims
- 2764US9765141B2Methods for preparing interferon alpha antibodiesMEDAREX LLC·Filed 2014·Granted Sep 19, 2017·0 cites·5 claims
- 2864US2017158767A1Human monoclonal antibodies to programmed death ligand 1 (pd-l1)SQUIBB & SONS LLC·Filed 2017·Application pending·0 cites
- 2962US2015203574A1Antibodies to il-6 and their usesPFIZER·Filed 2014·Application pending·0 cites
- 3062US2017369568A1Interferon alpha antibodies and their usesSQUIBB & SONS LLC·Filed 2017·Application pending·0 cites
- 3161US8846037B2Antibodies to IL-6 and their usesPFIZER·Filed 2013·Granted Sep 30, 2014·0 cites·33 claims
- 3257US8436158B2Antibodies to IL-6 and their usesRAJPAL ARVIND·Filed 2012·Granted May 7, 2013·0 cites·39 claims
- 3357US2005191293A1IP-10 antibodies and their usesFiled 2004·Application pending·0 cites
- 3453US2009175886A1Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residuesMEDAREX INC·Filed 2007·Application pending·0 cites
- 3551US2002072589A1Insulin-like growth factor binding protein variantsCELTRIX PHARMA·Filed 2001·Application pending·0 cites
- 3650US2017058031A1Human antibodies that bind cd22 and uses thereofSQUIBB & SONS LLC·Filed 2016·Application pending·0 cites
- 3750US2012276086A1Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residuesBLACK AMELIA NANCY·Filed 2012·Application pending·0 cites
- 3846US2003087806A1Pharmaceutical formulations for IGF/IGFBPINSMED INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David B. Passmore files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →